III 

115TH CONGRESS 

2D SESSION S. RES. 531 

Expressing support for the designation of May 2018 as ‘‘National Brain 

Tumor Awareness Month’’. 

IN THE SENATE OF THE UNITED STATES 

MAY 24, 2018 

Mr. DAINES (for himself, Mr. MARKEY, Ms. COLLINS, and Mr. VAN HOLLEN) 

submitted the following resolution; which was considered and agreed to 

RESOLUTION 

Expressing support for the designation of May 2018 as 

‘‘National Brain Tumor Awareness Month’’. 

Whereas an estimated 78,980 new cases of primary and nonmalignant tumors in the brain and central nervous system are expected to be diagnosed in the United States 

during calendar year 2018; 

Whereas up to 500,000 individuals were diagnosed with 

metastatic brain tumors that were the result of cancer 

spreading from another part of the body to the brain in 

2016; 

Whereas pediatric brain tumors are the leading cause of 

death from cancer in children under the age of 19; 

Whereas the average survival rate in the United States for 

all malignant brain tumor patients is only 34.9 percent; 


pbinns on DSK79D2C42PROD with BILLS
2 

•SRES 531 ATS 

Whereas an estimated 16,616 people in the United States will 

lose their battle with a primary brain tumor during calendar year 2018; 

Whereas brain tumors may be malignant or benign, but can 

be life-threatening in either case; 

Whereas nearly 700,000 people in the United States are currently living with a brain tumor; 

Whereas treatment of brain tumors is complicated by the fact 

that there are more than 130 different types of tumors; 

Whereas the treatment and removal of brain tumors present 

significant challenges because of the uniquely complex 

and fragile nature of the brain; 

Whereas brain tumors affect the primary organ in the human 

body that not only controls cognitive ability, but the actions of every other organ and limb in the body, leading 

to brain tumors being described as a disease that affects 

the whole individual; 

Whereas brain tumor research is supported by a number of 

private, nonprofit research foundations, and by institutes 

at the National Institutes of Health, including the National Cancer Institute and the National Institute for 

Neurological Disorders and Stroke; 

Whereas basic research advances may fuel research and development of new treatments for brain tumors; 

Whereas there remain challenging obstacles to the development of new treatments for brain tumors, and there are 

no strategies for screening or early detection of brain tumors; 

Whereas, despite the number of people newly diagnosed with 

a brain tumor every year, and their devastating progVerDate Sep 11 2014 03:46 May 25, 2018 Jkt 079200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6300 E:\BILLS\SR531.ATS SR531

pbinns on DSK79D2C42PROD with BILLS
3 

•SRES 531 ATS 

noses, there have only been 4 drugs and 1 device approved by the Food and Drug Administration to treat 

brain tumors during the preceding 30 years; 

Whereas the mortality rates associated with brain tumors 

have changed little during the past 30 years; 

Whereas there is a need for greater public awareness of brain 

tumors, including the difficulties associated with research 

on those tumors and the opportunities for advances in 

brain tumor research and treatment; and 

Whereas May 2018, when brain tumor advocates nationwide 

unite in awareness, outreach, and advocacy activities, is 

an appropriate month to recognize as ‘‘National Brain 

Tumor Awareness Month’’: Now, therefore, be it 

1 Resolved, That the Senate— 

2 (1) supports the designation of May 2018 as 

3 ‘‘National Brain Tumor Awareness Month’’; 

4 (2) encourages increased public awareness of 

5 brain tumors to honor those who have lost their lives 

6 to that devastating disease or are currently living 

7 with a brain tumor diagnosis; 

8 (3) supports efforts to develop better treat9 ments for brain tumors that will improve the quality 

10 of life and the long-term prognosis of those individ11 uals diagnosed with a brain tumor; 

12 (4) expresses its support for those individuals 

13 who are battling brain tumors, as well as the fami14 lies, friends, and caregivers of those individuals; and 


pbinns on DSK79D2C42PROD with BILLS
4 

•SRES 531 ATS 

1 (5) urges a collaborative approach to brain 

2 tumor research, which is a promising means of ad3 vancing understanding of, and treatment for, brain 

4 tumors. 

Æ 


pbinns on DSK79D2C42PROD with BILLS